In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Springworks Therapeutics ... The company was founded in August 2017 and is headquartered in Stamford, CT. Read More on ...

ATLANTA (AP) — Geno Smith passed for two touchdowns and Derick Hall returned a fumble 36 yards for a clinching score as the ...

Tesla’s model lineup is struggling and isn’t likely to be refreshed until late next year at the earliest, TD Cowen analyst ...

Fintel reports that on October 7, 2024, TD Cowen downgraded their outlook for Humana (NYSE:HUM) from Buy to Hold. Analyst Price Forecast Suggests 69.22% Upside As of September 25, 2024 ...

On Monday, TD Cowen upheld its Buy rating on Amazon.com (NASDAQ:AMZN) shares with a steady price target of $230.00. The firm anticipates an acceleration in the e-commerce giant's revenue growth ...

In a note on Monday downgrading their rating of Humana to "Hold" from "Buy", the TD Cowen analysts flagged that "[a]bsent successful appeal efforts, recovery of normalized margins may be pushed ...

TD Cowen upgraded CVS Health (NYSE:CVS) to Buy from Hold and raised its price target to $85 from $59 on Friday, citing an attractive risk-reward setup following several updates related to its ...

Investing.com -- Analysts at TD Cowen have raised their rating of CVS Health (NYSE:CVS) to "Buy" from "Hold", citing changes to its 2025 Medicare Advantage plan benefits announced earlier this week.

Fintel reports that on October 4, 2024, TD Cowen upgraded their outlook for CVS Health (SNSE:CVSCL) from Hold to Buy. There are 3,178 funds or institutions reporting positions in CVS Health.

TD Cowen has reaffirmed its Buy rating on Sun Country Airlines Holdings (NASDAQ: SNCY) with a steady price target of $20.00. The firm anticipates that the airline will announce its third-quarter ...

TD Cowen has reaffirmed its Buy rating on Sun Country Airlines Holdings (NASDAQ: SNCY) with a steady price target of $20.00. The firm anticipates that the airline will announce its third-quarter ...

TD Cowen on Monday upgraded Accenture (NYSE:ACN) to 'buy' with PT of $400, stating that the IT major has reinforced the demand stabilization theme and initial FY25 guide is appropriately ...